A specific autoantibody signature was seen in a subset of people with multiple sclerosis (MS) long before clinical symptoms ...

Join Dr. Osman in this engaging webinar as she delves into the cutting-edge world of autoantibody profiling to uncover predictive signatures of response and toxicity of immune checkpoint inhibitors ...

Johnson & Johnson (NYSE: JNJ) today announced results from additional analyses of the Phase 2 DAHLIAS study highlighting improvement in key measures of disease activity and significant IgG reduction ...

This milestone underscores our unwavering commitment to develop novel, transformational therapies that may help address significant unmet need for patients living with autoantibody-driven diseases." ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...